Compare LyondellBasell Industries NV (LYB) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LyondellBasell Industries NV vs Summit Therapeutics Inc — how do they compare? LyondellBasell Industries NV trades at $61.25 (market cap $19.60B), while Summit Therapeutics Inc trades at $14.58 (market cap $10.48B). The key difference: LyondellBasell Industries NV is the larger of the two by market cap, and LyondellBasell Industries NV pays a 6.78% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| LYB | SMMT | |
|---|---|---|
Market Cap | $19.60B | $10.48B |
Sector | Basic Materials | Health |
52-Week High | $82.38 | $29.32 |
52-Week Low | $42.28 | $13.05 |
Enterprise Value | $31.22B | $9.90B |
Dividend Yield | 6.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LyondellBasell (LYB) trades at $61.19, up 3.38% today, with a bullish technical signal and strong analyst consensus price target of $72.56. Recent earnings show volatility with Q1 2026 beating expectations, while Q4 2025 missed. The company maintains positive cash flow and recently announced a $0.69 dividend. Revenue has declined from $50.5B in 2022 to $30.2B in 2025, with net income turning negative at -$745M. News highlights include partnerships for sustainable packaging and anticipation of strong Q2 2026 earnings.
LYB presents a mixed outlook: potential upside exists from expected earnings recovery and strategic shifts toward high-margin polymers, but risks include declining revenue, negative profitability, and high debt. Investors should weigh the bullish analyst sentiment against fundamental challenges in the chemical sector.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LyondellBasell Industries NV
LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
